ZYVERSA THERAPEUTICS, INC. Expense Related to Distribution or Servicing and Underwriting Fees
ZYVERSA THERAPEUTICS, INC. (ZVSA) reported Expense Related to Distribution or Servicing and Underwriting Fees of $500.00 thousand for the 1-month period ending 2021-12-23, per its 10-K filed 2022-04-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ExpenseRelatedToDistributionOrServicingAndUnderwritingFees · last filed 2022-11-14
- 2021-12-23: Expense Related to Distribution or Servicing and Underwriting Fees $500.00K; Expense Related to Distribution or Servicing and Underwriting Fees 1 month $500.00K.
| Period end | Expense Related to Distribution or Servicing and Underwriting Fees | Expense Related to Distribution or Servicing and Underwriting Fees 1 month |
|---|---|---|
| 2021-12-23 | $500.00K 10-Q · filed 2022-11-14 | $500.00K 10-K · filed 2022-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |